4
Changes in Ownership
Summit Therapeutics Inc. Filed Acc 0000921895-20-002557
Options or other derivatives
- Chief Clinical Affairs Officer acquired 400,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Graham Camilla · Chief Clinical Affairs Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-10-04 | Grant or award : show line 1 in the form Stock Option (right to buy) | +400,000 | $3.34 | $1,336,000 | 400,000 | D |
Loading xslF345X03/form412566002_10072020.xml…